Jefferies analyst Brian Tanquilut reiterated a Hold rating on Cardinal Health (CAH) on November 9 and set a price target of $61. The company’s shares opened today at $57.31.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 5.5% and a 54.1% success rate. Tanquilut covers the Services sector, focusing on stocks such as Addus Homecare Corp, Laboratory Corp, and Amedisys.
Currently, the analyst consensus on Cardinal Health is a Hold with an average price target of $54.67, representing a -4.6% downside. In a report issued on November 8, Mizuho Securities also maintained a Hold rating on the stock with a $55 price target.
.
See today’s analyst top recommended stocks >>
Based on Cardinal Health’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $35.21 billion and net profit of $593 million. In comparison, last year the company earned revenue of $32.64 billion and had a net profit of $115 million.
Based on the recent corporate insider activity of 41 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States.
